Mafenide Acetate

醋酸磺胺米隆

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMafenide Acetate
Drug Alias Namemafenida苯磺酰胺醋酸盐醋酸甲磺灭脓mafenidum醋酸甲磺米脓 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCarbonic anhydrase VI inhibitors
TargetsCarbonic anhydrase VI
Therapy Area/IndicationsBurnsInfections
Global Approved IndicationsBurnsInfections
Approved Indications in ChinaBurnsInfections
Original Approved Country/TerritoryUnited States
Original Approved Date1969/01/24
Country/TerritoryCanadaUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesRising Pharma Holdings Inc
Inactive CompaniesMylan Bertek Pharmaceuticals IncUniversity Of Texas Medical Branch
Active IndicationsBurnsInfections
Inactive IndicationsN/A

Other Information

ATC CodeD06BA03
Related LinksWikipediaDrugBankKEGG